Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
Background: Oestradiol with or without an anti-androgen (cyproterone acetate or spironolactone) is commonly prescribed in transfeminine individuals who have not had orchidectomy; however, there is no evidence to guide optimal treatment choice. Objective: We aimed to compare add-on cyproterone acet...
Gorde:
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Bioscientifica
2019-07-01
|
| Saila: | Endocrine Connections |
| Gaiak: | |
| Sarrera elektronikoa: | https://ec.bioscientifica.com/view/journals/ec/8/7/EC-19-0272.xml |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|